Clincosm LogoSign in Get a demo

Risk Factors for Aneurysm Rebleeding

Sponsor
Fujian Medical University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01567449
Collaborator
(none)
66
Enrollment
1
Location
7
Duration (Months)
9.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to examine the risk factors for aneurysm rebleeding.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To investigate risk factors for spontaneous aneurysm rebleeding during hospitalization and to reach conclusions if any,of clinical signs for predicting rebleeding.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    66 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Risk Factors in Predicting Spontaneous Intracranial Aneurysm Rebleeding During Hospitalization
    Study Start Date :
    Sep 1, 2011
    Actual Primary Completion Date :
    Mar 1, 2012
    Anticipated Study Completion Date :
    Apr 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    the case group

    The case group referred to SAH patients with aneurysm rebleeding
    the control group

    the control group referred to SAH patients not with aneurysm rebleeding

    Outcome Measures

    Primary Outcome Measures

    1. Aneurysm rebleeding [up to 7 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Individual whose clinical course was clear enough to be traced back and whose conservative treatment duration was shorter than 6 weeks was included
    Exclusion Criteria:

    • Rebleeding patients with certain inducing factors such as:

    • severe emotional episode,

    • severe coughing,

    • constipation,

    • excessive activities, or

    • with coagulation disorder,or

    • with other intracranial vascular malformations,such as:

    • moyamoya disease,

    • arteriovenous malformation were excluded.

    • Also patients who rebled while angiography were excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 First Affiliated Hospital,Fujian Medical University Fuzhou Fujian China 350005

    Sponsors and Collaborators

    • Fujian Medical University

    Investigators

    • Study Director: Dezhi kang, professor, First Affiliated Hospital of Fujian Medical University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Qingsong Lin, Junior Doctor of Neurosurgery,Principal Investigator,Clinical Doctor, Fujian Medical University
    ClinicalTrials.gov Identifier:
    NCT01567449
    Other Study ID Numbers:
    • 110011
    First Posted:
    Mar 30, 2012
    Last Update Posted:
    Mar 30, 2012
    Last Verified:
    Mar 1, 2012
    Additional relevant MeSH terms:
    Subarachnoid Hemorrhage
    Aneurysm
    Hemorrhage

    Study Results

    No Results Posted as of Mar 30, 2012